Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-035340
Filing Date
2025-07-18
Accepted
2025-07-18 16:11:46
Documents
1
Period of Report
2025-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1752869497.html 4  
1 FORM 4 wk-form4_1752869497.xml 4 24985
  Complete submission text file 0001628280-25-035340.txt   26531
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 750 BATTERY STREET, SUITE 330 SAN FRANCISCO CA 94111
Business Address
Taub Rebecca (Reporting) CIK: 0001423898 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 251134632